Abstract:Background: The prevalence of diabetes is predicted to rise significantly in the coming decades. A recent analysis projects that by the year 2030 there will be ~366 million diabetics around the world, leading to an increased demand for inexpensive insulin to make this life-saving drug also affordable for resource poor countries. Results: A synthetic insulin precursor (IP)-encoding gene, codon-optimized for expression in P. pastoris, was cloned in frame with the Saccharomyces cerevisiae alpha-factor secretory signal and integrated into the genome of P. pastoris strain X-33. The strain was grown to high-cell density in a batch procedure using a defined medium with low salt and high glycerol concentrations. Following batch growth, production of IP was carried out at methanol concentrations of 2 g L-1, which were kept constant throughout the remaining production phase. This robust feeding strategy led to the secretion of approximately 3 gram IP per liter of culture broth (corresponding to almost 4 gram IP per liter of cell-free culture supernatant). Using immobilized metal ion affinity chromatography (IMAC) as a novel approach for IP purification, 95% of the secreted product was recovered with a purity of 96% from the clarified culture supernatant. Finally, the purified IP was trypsin digested, transpeptidated, deprotected and further purified leading to approximately 1.5 g of 99% pure recombinant human insulin per liter of culture broth. Conclusions: A simple two-phase cultivation process composed of a glycerol batch and a constant methanol fed-batch phase recently developed for the intracellular production of the Hepatitis B surface antigen was adapted to secretory IP production. Compared to the highest previously reported value, this approach resulted in an ~2 fold enhancement of IP production using Pichia based expression systems, thus significantly increasing the efficiency of insulin manufacture.

Research on Preparation of Insulin Aspart with Short C-Peptide

Study on directed enzymatic preparation from casein based on simulated peptide-cut

Cloning,expression and purification of recombinant human proinsulin C-peptide in E.coli

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain

Two-step transpeptidation of the insulin precursor expressed in Pichia pastoris to insulin ester via trypsin-catalyzed cleavage and coupling.

N-Terminal Heterogeneity and Purification of Insulin Precursor Expressed in Pichia Pasoris

A New Method for Preparation of Monomeric Destetrapeptide Human Insulin

Separation and Purification of Recombinant Human Insulin and C Peptide Expressed in the Yeast Pichia Pastoris

Construction, Preparation and Properties of a Novel Short-Acting Human Insulin Analog

Cloning, Expression, and Purification of Recombinant Human-Insulin Analogue Gene in E.coli

Preparation of Tyr-C-peptide from genetically altered human insulin precursor.

Application of Recombinant Carboxypeptidase B in the Preparation of Proinsulin C-peptide

Expression of monomeric insulin precursor in Pichia pastoris and its conversion into monomeric B27 Lys destripeptide insulin by tryptic hydrolysis.

Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin

An Efficient Trypsin Digestion Strategy for Improving Desb30 Productivity from Recombinant Human Insulin Precursor Fusion Protein

One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique

Preparation and Pharmacodynamics Study of a Novel Rapid-Acting An-alog of Human Insulin

Research of Recombinant Lysine Endopeptidase Construction Expression and Activity

Expression and Purification of Peptide P277 and Its Primary Pharmacology

Expression, purification, and characterization of the Degludec precursor DesB30